RM
+
Illustration of the human voltage-gated potassium (Kv) ion channel Kv42 in complex with its dipeptidyl peptidase-related protein 6 (DPP6) modulator
RF
+
Sitagliptin pill conceptual image
RM
+
Human voltage-gated potassium channel complexed with dipeptidyl aminopeptidase-like protein 6 molecular model The image shows the potassium voltage-
RM
+
Voltage-gated potassium channel complex molecular model
RM
+
Dipeptidyl peptidase 4 molecular model
RM
+
Neurological effects of diabetes drugs Conceptual image of a human brain enclosed in a hollow icosahedron with its edges consisting of various drugs
RM
+
Vildagliptin diabetes drug molecule computer model Vildagliptin which is marketed as Galvus by Novartis belongs to the dipeptidyl peptidase-4 (DPP
RM
+
Vildagliptin diabetes drug molecule computer model Vildagliptin which is marketed as Galvus by Novartis belongs to the dipeptidyl peptidase-4 (DPP
RF
+
Glucagon-like peptide 1 molecule illustration
ED
+
Januvia diabetes drug molecular model Januvia (sitagliptin) is a hypoglycaemic drug one that reduces blood sugar levels Diabetes is a condition in
RF
+
Berberine herbal medicine molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles hydrogen (hidden) carbon
RF
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Stylized skeletal formula (ch
RF
+
Sitagliptin diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles hydrogen (hidden) carbon
RF
+
Saxagliptin diabetes drug molecule Inhibitor of dipeptidyl peptidase-4 (DPP4) Stylized skeletal formula (chemical structure) Atoms are shown as col
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as colo
RF
+
Alogliptin diabetes drug molecule
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Atoms are represented as spheres with conventional colour coding hydro
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Atoms are represented as spheres with conventional colour coding hydro
RF
+
Linagliptin diabetes drug molecule
RF
+
Linagliptin diabetes drug molecule
RF
+
Vildagliptin diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick black outlines
RF
+
Vildagliptin diabetes drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Vildagliptin diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by thin bonds o
RF
+
Vildagliptin diabetes drug molecule Blue skeletal formula on white background
RF
+
Teneligliptin diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick black outlines
RF
+
Teneligliptin diabetes drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Teneligliptin diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by thin bonds
RF
+
Teneligliptin diabetes drug molecule Blue skeletal formula on white background
RF
+
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as colo
RF
+
Linagliptin diabetes drug molecule illustration
RF
+
Linagliptin diabetes drug molecule illustration
RF
+
Linagliptin diabetes drug molecule illustration
RM
+
Alogliptin diabetes drug molecule
RM
+
Alogliptin diabetes drug molecule
RM
+
Alogliptin diabetes drug molecule
RM
+
Alogliptin diabetes drug molecule Belongs to dipeptidyl peptidase 4 (DPP-4) or gliptin class of antidiabetic medicines Blue skeletal formula on whit
RM
+
Dipeptidyl peptidase 4 Computer model showing the structure of dipeptidyl peptidase 4 (DPP4) DPP4 is a dimer of identical subunits A 3-mer peptide
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Berberine herbal medicine molecular model Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (black) nitrog
44
0
https://www.afloimages.com/search/dipeptidyl.html